GlassScriptPhysician profile
Haley Ann Waters
NPI 1841967221
$985.46
in general payments reported to CMS, 2019-2025
18 companies · $87.28 in 2025
The $87.28 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $624 · 2024: $274 · 2025: $87.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $985.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $985.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $163.35 | 2024-2025 | |
| Lilly USA, LLC | $121.81 | 2023 | Olumiant |
| Astrazeneca Pharmaceuticals LP | $110.40 | 2023 | Farxiga |
| Novartis Pharmaceuticals Corporation | $84.94 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $74.38 | 2023 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $60.66 | 2023-2024 | Lifevest |
| Aerin Medical INC. | $48.29 | 2024 | |
| Scpharmaceuticals INC. | $42.74 | 2023 | |
| Lexicon Pharmaceuticals, INC. | $40.69 | 2023 | Inpefa |
| Pfizer INC. | $39.70 | 2024 | |
| Glaxosmithkline, LLC. | $39.45 | 2024-2025 | Nucala |
| Merck Sharp & Dohme LLC | $37.71 | 2023 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $27.18 | 2024 | Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.30 | 2023 | Jardiance |
| Philips North America LLC | $21.26 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $18.98 | 2023 | Repatha |
| Kiniksa Pharmaceuticals, LTD. | $15.95 | 2023 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $15.67 | 2023 | Onpattro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Waters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.